Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Literature DB >> 1159622

Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

J R Koup, D J Greenblatt, W J Jusko, T W Smith, J Koch-Weser.

Abstract

Entities: Chemical

Mesh：

Substances：
Digoxin

Year: 1975 PMID： 1159622 DOI： 10.1007/bf01067907

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

18 in total

Review 1. Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy.

Authors: J G Wagner
Journal: Am Heart J Date: 1974-08 Impact factor: 4.749

2. Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

Authors: W G Kramer; R P Lewis; T C Cobb; W F Forester; J A Visconti; L A Wanke; H G Boxenbaum; R H Reuning
Journal: J Pharmacokinet Biopharm Date: 1974-08

3. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].

Authors: E E Ohnhaus; P Spring; L Dettli
Journal: Dtsch Med Wochenschr Date: 1974-09-13 Impact factor: 0.628

4. Renal tubular secretion of digoxin.

Authors: E Steiness
Journal: Circulation Date: 1974-07 Impact factor: 29.690

5. The specificity of the digoxin radioimmunoassay procedure.

Authors: R G Stoll; M S Christensen; E Sakmar; J G Wagner
Journal: Res Commun Chem Pathol Pharmacol Date: 1972-11

6. Digoxin metabolism in obesity.

Authors: G A Ewy; B M Groves; M F Ball; L Nimmo; B Jackson; F Marcus
Journal: Circulation Date: 1971-11 Impact factor: 29.690

7. An improved method of digoxin therapy.

Authors: R W Jelliffe
Journal: Ann Intern Med Date: 1968-10 Impact factor: 25.391

8. Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man.

Authors: W Shapiro; K Narahara; K Taubert
Journal: Circulation Date: 1970-12 Impact factor: 29.690

9. Relationship of the excretion of tritiated digoxin to renal function.

Authors: P M Bloom; W B Nelp; S H Tuell
Journal: Am J Med Sci Date: 1966-02 Impact factor: 2.378

10. The metabolism of tritiated digoxin in renal insufficiency in dogs and man.

Authors: F I Marcus; A Peterson; A Salel; J Scully; G G Kapadia
Journal: J Pharmacol Exp Ther Date: 1966-06 Impact factor: 4.030

51 in total

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Review 1. Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy.

2. Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

3. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].

4. Renal tubular secretion of digoxin.

5. The specificity of the digoxin radioimmunoassay procedure.

6. Digoxin metabolism in obesity.

7. An improved method of digoxin therapy.

8. Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man.

9. Relationship of the excretion of tritiated digoxin to renal function.

10. The metabolism of tritiated digoxin in renal insufficiency in dogs and man.

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Review 2. Therapeutic drug monitoring of antiarrhythmic drugs.

3. Altered distribution of digoxin in renal failure--a cause of digoxin toxicity?

Review 4. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

5. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.

Review 6. Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Review 7. Contemporary Controversies in Digoxin Use in Systolic Heart Failure.

Review 8. Clinical pharmacokinetics of digoxin.

Review 9. Clinical pharmacokinetics of digoxin in infants.

10. Plasma and urinary digoxin in thyroid dysfunction.